Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Metzger

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Leukemia|January 26, 2019
LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AMLJessica Barth, Khalil Abou-El-Ardat, Denis Dalic, et al.
European Journal of Haematology|June 3, 2025
Sensitization of Non-M3 Acute Myeloid Leukemia Blasts to All-Trans Retinoic Acid by the LSD1 Inhibitor Tranylcypromine: TRANSATRA Phase I StudyMichael Kruszewski, Claudia Schmoor, Tobias Berg, et al.
Cell Death & Disease|August 14, 2025
Lysine-specific demethylase 1 regulates hematopoietic stem cell expansion and myeloid cell differentiationHans Felix Staehle, Christoph Koellerer, Anne Marie Staehle, et al.
Nature Communications|January 3, 2024
Structure-guided design of a selective inhibitor of the methyltransferase KMT9 with cellular activitySheng Wang, Sebastian O Klein, Sylvia Urban, et al.
JCI Insight|March 9, 2026
Lysine-specific histone demethylase 1a regulates nephron development and long-term transcriptional programmingNicola Wanner, Julia Keller, Nastassia Liaukouskaya, et al.
Nature Structural & Molecular Biology|January 12, 2016
Assembly of methylated KDM1A and CHD1 drives androgen receptor-dependent transcription and translocationEric Metzger, Dominica Willmann, Joel McMillan, et al.
Journal of Medicinal Chemistry|June 17, 2025
Structure-Guided Design of a KMT9 Inhibitor Prodrug with Cellular ActivitySheng Wang, Nicolas P F Barthes, Sylvia Urban, et al.
Journal of Medicinal Chemistry|May 5, 2026
Development of High-Affinity CHD1 Chromodomain InhibitorsHolger Greschik, Florian Friedrich, Ludwig Seifert, et al.
Cancer Letters|November 30, 2025
KDM4A promotes NEPC progression through regulation of MYC expressionCelia Sze Ling Mak, Ming Zhu, Jie Fu, et al.
Blood|October 27, 2025
Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AMLViktor Fetsch, Lennard Frederik Schwöbel, Ezgi Ozyerli-Goknar, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Leukemia|January 26, 2019
LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AMLJessica Barth, Khalil Abou-El-Ardat, Denis Dalic, et al.
European Journal of Haematology|June 3, 2025
Sensitization of Non-M3 Acute Myeloid Leukemia Blasts to All-Trans Retinoic Acid by the LSD1 Inhibitor Tranylcypromine: TRANSATRA Phase I StudyMichael Kruszewski, Claudia Schmoor, Tobias Berg, et al.
Cell Death & Disease|August 14, 2025
Lysine-specific demethylase 1 regulates hematopoietic stem cell expansion and myeloid cell differentiationHans Felix Staehle, Christoph Koellerer, Anne Marie Staehle, et al.
Nature Communications|January 3, 2024
Structure-guided design of a selective inhibitor of the methyltransferase KMT9 with cellular activitySheng Wang, Sebastian O Klein, Sylvia Urban, et al.
JCI Insight|March 9, 2026
Lysine-specific histone demethylase 1a regulates nephron development and long-term transcriptional programmingNicola Wanner, Julia Keller, Nastassia Liaukouskaya, et al.
Nature Structural & Molecular Biology|January 12, 2016
Assembly of methylated KDM1A and CHD1 drives androgen receptor-dependent transcription and translocationEric Metzger, Dominica Willmann, Joel McMillan, et al.
Journal of Medicinal Chemistry|June 17, 2025
Structure-Guided Design of a KMT9 Inhibitor Prodrug with Cellular ActivitySheng Wang, Nicolas P F Barthes, Sylvia Urban, et al.
Journal of Medicinal Chemistry|May 5, 2026
Development of High-Affinity CHD1 Chromodomain InhibitorsHolger Greschik, Florian Friedrich, Ludwig Seifert, et al.
Cancer Letters|November 30, 2025
KDM4A promotes NEPC progression through regulation of MYC expressionCelia Sze Ling Mak, Ming Zhu, Jie Fu, et al.
Blood|October 27, 2025
Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AMLViktor Fetsch, Lennard Frederik Schwöbel, Ezgi Ozyerli-Goknar, et al.
Pageof 6